Discontinuation report MIDAZOLAM INJECTION
Report ID | 125902 |
Drug Identification Number | 02423766 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | MIDAZOLAM INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5mL ampoules |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | |
Remaining supply date | |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.